8-K filed October 7, 2025, 7:59 PM ET CIK 0001604950

M&A confidence high sentiment neutral materiality 1.00

MannKind completes acquisition of scPharmaceuticals for $5.35/sh plus CVR; stock delisted

scPharmaceuticals Inc.

Merger closed Oct 7, 2025; shareholders receive $5.35 cash + up to $1.00 CVR per share.
Approximately 84.4% of shares tendered (73.5% valid tender + 10.9% guaranteed delivery).
Company terminated existing credit agreement and repurchased revenue participation rights upon merger close.
All directors resigned; new board appointed from MannKind (Michael Castagna, David Thomson, Chris Prentiss).
Shares halted on Nasdaq; company will file Form 15 to deregister reporting obligations.

item 1.02 item 2.01 item 3.01 item 3.03 item 5.01 item 5.02 item 5.03 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-232754
form_type: 8-K
ticker: null
cik: 0001604950
company_name: scPharmaceuticals Inc.
filed_at: 2025-10-07T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.899074+00:00
generated_at: 2026-05-17T04:26:30.016120+00:00
sec_items: ["1.02", "2.01", "3.01", "3.03", "5.01", "5.02", "5.03", "9.01"]
event_type: m_and_a
sentiment: neutral
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-232754
json_url: https://secwatch.observer/filing/0001193125-25-232754.json
markdown_url: https://secwatch.observer/filing/0001193125-25-232754.md
text_url: https://secwatch.observer/filing/0001193125-25-232754.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1604950/000119312525232754/0001193125-25-232754-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1604950/000119312525232754/d20686d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

2061095a0caa4e5b77f4e3c449d04b4fc1035ae9

scPharmaceuticals Inc.: Second amended and restated certificate of incorporation amended and restated in entirety (effective 2025-10-07).

on October 7, 2025, the Company’s second amended and restated certificate of incorporation and amended and restated bylaws were each amended and restated in their entirety

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

6290035b805eaaa86cc189f52cf7804fb1ffd60c

scPharmaceuticals Inc.: Amended and restated bylaws amended and restated in entirety (effective 2025-10-07).

on October 7, 2025, the Company’s second amended and restated certificate of incorporation and amended and restated bylaws were each amended and restated in their entirety

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

6f7f42f02e69f8588d53d51ae64e02c58809d781

scPharmaceuticals Inc. underwent a change of control involving MannKind Corporation for $5.35 in cash plus one non-tradable contingent value right per Share (closed 2025-10-07).

commenced a tender offer to purchase all the outstanding shares of the Company’s common stock, par value $0.0001 per share (the “ Shares ”), at a price per Share of (i) $5.35 in cash (the “ Cash Amount ”), without interest, subject to any applicable withholding taxes and (ii) one non-tradable contingent value right (each, a “ CVR ”) per Share, which

SEC 8-K Item 2.01/5.01 confidence 0.9 SEC evidence

Comparable filings

FARM

Farmer Brothers taken private by Royal Cup for $1.29/share; merger closes May 5, 2026

FARMER BROTHERS CO May 5, 2026, 7:59 PM ET m_and_a Items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01

same fact type: governance_change, ma_transaction same SEC item: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

on October 7, 2025, the Company’s second amended and restated certificate of incorporation and amended and restated bylaws were each amended and restated in their entirety

Comparable filing

the Certificate of Incorporation of the Company that was in effect immediately before the Effective Time was amended and restated to be in the form attached hereto as Exhibit 3.1

Filing page SEC filing

CHRN

Ekso Bionics completes reverse merger with Applied Digital subsidiary; renames to ChronoScale Corp.

EKSO BIONICS HOLDINGS, INC. May 5, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 2.02, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 9.01

same fact type: governance_change, ma_transaction same SEC item: 2.01, 3.03, 5.01, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

on October 7, 2025, the Company’s second amended and restated certificate of incorporation and amended and restated bylaws were each amended and restated in their entirety

Comparable filing

on May 1, 2026, the Company filed the Second Amended and Restated Articles of Incorporation (the “A&R Articles”) with the Secretary of State of the State of Nevada with a delayed effective date and time of 3:00 a.m. (Eastern Time) on May 5, 2026.

Filing page SEC filing

UHG

Stanley Martin completes $221M all-cash acquisition of United Homes at $1.18/share

United Homes Group, Inc. May 4, 2026, 7:59 PM ET m_and_a Items 1.02, 2.01, 3.01, 3.02, 3.03, 5.03, 5.01, 5.02, 8.01, 9.01

same fact type: governance_change, ma_transaction same SEC item: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

on October 7, 2025, the Company’s second amended and restated certificate of incorporation and amended and restated bylaws were each amended and restated in their entirety

Comparable filing

Effective upon completion of the Merger, the bylaws of the Company, as in effect immediately prior to the Effective Time, were amended and restated to be in the form of the bylaws filed herewith as Exhibit 3.2.

Filing page SEC filing

Enviri II Corp

New Enviri completes spin-off; starts trading June 2 under NVRI; ~$1.2B revenue, ~$140M EBITDA

Enviri II Corp June 1, 2026, 5:18 PM ET m_and_a Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 7.01, 9.01

same fact type: governance_change, ma_transaction same SEC item: 3.03, 5.01, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

on October 7, 2025, the Company’s second amended and restated certificate of incorporation and amended and restated bylaws were each amended and restated in their entirety

Comparable filing

In connection with the Spin-Off, the Board adopted the Code of Conduct, a copy of which is available on New Enviri’s website at www.enviri.com.

Filing page SEC filing

NVRI

Enviri completes sale of Clean Earth to Veolia for $3.04B; spins off remaining businesses as New Enviri

ENVIRI Corp June 1, 2026, 5:15 PM ET m_and_a Items 1.02, 2.01, 3.01, 3.03, 5.01, 9.01

same fact type: ma_transaction same SEC item: 1.02, 2.01, 3.01, 3.03, 5.01, 9.01 same event type: m_and_a similar materiality

This filing

commenced a tender offer to purchase all the outstanding shares of the Company’s common stock, par value $0.0001 per share (the “ Shares ”), at a price per Share of (i) $5.35 in cash (the “ Cash Amount ”), without interest, subject to any applicable withholding taxes and (ii) one non-tradable contingent value right (each, a “ CVR ”) per Share, which

Comparable filing

On June 1, 2026, pursuant to the terms of the Separation Agreement and the Merger Agreement, the following series of transactions occurred

Filing page SEC filing

CTLP

Cantaloupe completes merger with 365 Retail Markets; shareholders receive $11.20/share

CANTALOUPE, INC. May 8, 2026, 7:59 PM ET m_and_a Items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 9.01

same fact type: ma_transaction same SEC item: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 9.01 same event type: m_and_a similar materiality

This filing

commenced a tender offer to purchase all the outstanding shares of the Company’s common stock, par value $0.0001 per share (the “ Shares ”), at a price per Share of (i) $5.35 in cash (the “ Cash Amount ”), without interest, subject to any applicable withholding taxes and (ii) one non-tradable contingent value right (each, a “ CVR ”) per Share, which

Comparable filing

Rollover Shares immediately prior to the Effective Time, and were canceled at the Effective Time for no consideration) were canceled and converted into the right to receive $11.20 in cash, without interest (such amount per share, the “ Merger Consideration ”). At the Effective Time, (i) each Company RSU (as defined in the Merger Agreement) that was

Filing page SEC filing

CTRA

Coterra Energy completes merger with Devon; shares converted at 0.70x ratio

Coterra Energy Inc. May 7, 2026, 7:59 PM ET m_and_a Items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 9.01

same fact type: ma_transaction same SEC item: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 9.01 same event type: m_and_a similar materiality

This filing

commenced a tender offer to purchase all the outstanding shares of the Company’s common stock, par value $0.0001 per share (the “ Shares ”), at a price per Share of (i) $5.35 in cash (the “ Cash Amount ”), without interest, subject to any applicable withholding taxes and (ii) one non-tradable contingent value right (each, a “ CVR ”) per Share, which

Comparable filing

ith Devon Energy Corporation, a Delaware corporation (“Devon”), and Cubs Merger Sub, Inc., a Delaware corporation and

Filing page SEC filing

PKST

Brookfield completes $1.2B acquisition of Peakstone Realty Trust at $21.00/share

Peakstone Realty Trust May 6, 2026, 7:59 PM ET m_and_a Items 2.01, 3.01, 3.02, 5.03, 3.03, 5.01, 5.02, 8.01, 9.01

same fact type: governance_change same SEC item: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

on October 7, 2025, the Company’s second amended and restated certificate of incorporation and amended and restated bylaws were each amended and restated in their entirety

Comparable filing

In addition, at the Company Merger Effective Time, the bylaws of the Company that were in effect immediately prior to the Company Merger Effective Time were amended and restated in their entirety in the form attached hereto as Exhibit 3.2 and became the bylaws of the Surviving Company.

Filing page SEC filing

Source: SEC EDGAR

accession 0001193125-25-232754

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.